Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Genetic Landscape of Ocular Adnexa Extranodal Marginal Zone Lymphoma

Marco Magistri, PhD MS, Lanie Happ, Jeremy Ramdial, MD, Kranthi Kunkalla, Sander R Dubovy, MD, Jennifer R Chapman, MD, Francisco Vega, MD PhD, Sandeep Dave, MD, Izidore S. Lossos, MD

Blood (2018) 132 (Supplement 1): 923.

https://doi.org/10.1182/blood-2018-99-111325

Published: 2018

Journal Articles

Limited Role of Workup Including PET-CT, Esophagogastroduodenoscopy and Bone Marrow Biopsy in Staging of Ocular Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Type

Heejung Chae, Cheolwon Suh, Dok Hyun Yoon, Jung Yong Hong, Chan-Sik Park, Jooryung Huh, Ho-Seok Sa, Kyoung Won Kim

Blood (2016) 128 (22): 2988.

https://doi.org/10.1182/blood.V128.22.2988.2988

Published: 2016

Journal Articles

R-CVP Chemoimmunotherapy for Limited-Stage Ocular Adnexal MALT Lymphoma with Adverse Factors: A Phase II Study

Sung-Yong Kim, MD, Seok-Goo Cho, Won-Sik Lee, MD, Suk-Woo Yang, MD, Sung Yong Oh, MD, Hee Bae Ahn, MD, Deok-Hwan Yang, Seong Kyu Park, Jee Ho Chang, MD, Hyo Jung Kim, MD PhD, Min Joung Lee, Jae Wook Yang

Blood (2016) 128 (22): 2981.

https://doi.org/10.1182/blood.V128.22.2981.2981

Published: 2016

Journal Articles

A Novel Prognostic Index for Ocular Adnexal Lymphoma

Marshall W. Meeks, BS, Henry S. Park, MD MPH, James B. Yu, MD MHS, Kenneth B. Roberts, MD, Francine Foss, MD, Lynn D. Wilson, MD MPH

Blood (2016) 128 (22): 3597.

https://doi.org/10.1182/blood.V128.22.3597.3597

Published: 2016

Journal Articles

Chemotherapy Alone Is Effective to Treat Localized and Disseminated Ocular Adnexa Lymphomas

Wei-Li Ma, MD

Blood (2015) 126 (23): 2709.

https://doi.org/10.1182/blood.V126.23.2709.2709

Published: 2015

Journal Articles

Ocular Adnexal Marginal Zone Lymphomas (OAMZL): Lack of Evidence for Chlamydia Psittaci (C. Psittaci) Infection in a Clinicopathologic Study from a Single Institution

Brayan Marcel Merchán, MD, Anny Jaramillo, MD, Teresa Tortola, Pau Abrisqueta, MD, Josep Castellvi, MD, Ramón Medel, MD, Katia Flores, MD, Javier Hernandez, MD, Mercedes Gironella, MD, Andres Lopez-Hernandez, MD PhD, Francesc Bosch, MD PhD

Blood (2014) 124 (21): 4467.

https://doi.org/10.1182/blood.V124.21.4467.4467

Published: 2014

Journal Articles

Ocular Adnexal Lymphomas (OALs) At Conjunctiva Present a Remarkable Good Prognosis : Oals Study Of 83 Cases At a Single Institution

Aya Ouchi, MD, Masahiro Yokoyama, M.D, Kenji Nakano, MD, Kengo Takeuchi, MD, PhD, Hideki Tsuji, Hideaki Nitta, M.D, Kyoko Ueda, M.D, Noriko Nishimura, M.D., Ph D, Naoko Tsuyama, M.D., Yasuhito Terui, M.D., Ph D, Kiyohiko Hatake, M.D., Ph D

Blood (2013) 122 (21): 4336.

https://doi.org/10.1182/blood.V122.21.4336.4336

Published: 2013

Journal Articles

MicroRNA Profiling in Low-Grade Ocular MALT and Diffuse Large B-Cell Lymphoma: A Role for MYC and NFKB1 Mediated Dysregulation of MicroRNA Expression in Aggressive Disease

Christoffer Hother, MD, Peter Kristian Rasmussen, MD, Tejal Joshi, PhD, Ditte Reker, Ulrik Ralfkiaer, MSc, Christopher Workman, PhD, Peter De Nully Brown, Steffen Heegaard, Prof. MD, Elisabeth Ralfkiaer, Prof., MD, DMSc, Kirsten Grønbæk, MD, DMSc

Blood (2012) 120 (21): 1600.

https://doi.org/10.1182/blood.V120.21.1600.1600

Published: 2012

Journal Articles

Rituximab and Chlorambucil As First Line Therapy of Low-Grade Ocular Adnexal Lymphomas: Long Term Follow-up Results

Benedetta Puccini, Luigi Rigacci, MD, Marco Puccioni, Sofia Kovalchuk, Elisa Fabbri, Valentina Carrai, Renato Alterini, Alberto Bosi, MD

Blood (2012) 120 (21): 3685.

https://doi.org/10.1182/blood.V120.21.3685.3685

Published: 2012

Journal Articles

Primary and Secondary Ocular Adnexal Lymphoma: A Single Institutional Experience

Darcie Deaver, MS, ARNP, Kenneth S. Zuckerman, MD, Celeste M. Bello, MD, Eduardo M. Sotomayor, Salvador Bruno, MD, Lubomir Sokol, MD, PhD

Blood (2011) 118 (21): 4956.

https://doi.org/10.1182/blood.V118.21.4956.4956

Published: 2011

Journal Articles

Extranodal marginal zone lymphoma of the ocular adnexa

Alexandra Stefanovic, Izidore S. Lossos

Blood (2009) 114 (3): 501–510.

https://doi.org/10.1182/blood-2008-12-195453

Published: 2009

Journal Articles

Immunoglobulin Gene Repertoire in Ocular Adnexa Lymphomas (OAL): Hints on the Nature of the Antigenic Stimulation

Antonis Dagklis, Maurilio Ponzoni, MD, Andres JM Ferreri, MD, Maria Giulia Cangi, Lorenza Pecciarini, Riccardo Dolcetti, Kostas Stamatopoulos, MD, Claudio Doglioni, MD, Paolo Ghia, MD, PhD

Blood (2008) 112 (11): 623.

https://doi.org/10.1182/blood.V112.11.623.623

Published: 2008

Journal Articles

First Line Treatment with Rituximab and Chlorambucil in the Treatment of Ocular Adnexal Lymphomas.

Luigi Rigacci, MD, Marco Puccioni, MD, Luca Nassi, MD, Silvia Mappa, MD, Cinzia Mazzini, MD, Renato Alterini, MD, Valentina Carrai, MD, Ennio Polito, MD, Alberto Bosi, MD

Blood (2006) 108 (11): 4712.

https://doi.org/10.1182/blood.V108.11.4712.4712

Published: 2006

Journal Articles

High Prevalence of Helicobacter pylori ( Hp ) Infection in Ocular Adnexal Lymphoma (OAL).

Patricia Validire, Marc Lecuit, Anne Vincent-Salomon, Patricia de Cremoux, Eric Abachin, Corine Plancher, Martine Thioux, Philippe Arnaud, Livia Lumbroso-Le Rouic, Remi Dendale, Bernard Asselain, Jessica Konopka, Rafika Sahli, Didier Decaudin

Blood (2006) 108 (11): 4597.

https://doi.org/10.1182/blood.V108.11.4597.4597

Published: 2006

Journal Articles

Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci

Manuel F. Rosado, Gerald E. Byrne, Jr, Feying Ding, Kenneth A. Fields, Phillip Ruiz, Sander R. Dubovy, Gale R. Walker, Arnold Markoe, Izidore S. Lossos

Blood (2006) 107 (2): 467–472.

https://doi.org/10.1182/blood-2005-06-2332

Published: 2006

Journal Articles

Ocular Adnexal Lymphoma: A Clinicopathological Study of a Large Cohort of Patients with No Evidence for an Association with Chlamydia psittaci .

Manuel F. Rosado, MD, Gerald E. Byrne, MD, Feying Ding, Keneth A. Fields, PhD, Phillip A. Ruiz, MD, Sander R. Dubovy, MD, Gale R. Walker, Arnold Markoe, MD, Lossos S. Izidore, MD

Blood (2005) 106 (11): 978.

https://doi.org/10.1182/blood.V106.11.978.978

Published: 2005

Journal Articles

Is There an Association between Ocular Adnexal Lymphoma and Chlamydia psittaci Infection? The University of Rochester Experience.

Paul G. Rothberg, PhD, Roberto L. Vargas, MD, Enzo Fallone, MD, Arthur A. Andersen, DVM, PhD, Raymond E. Felgar, MD, PhD

Blood (2005) 106 (11): 998.

https://doi.org/10.1182/blood.V106.11.998.998

Published: 2005

Journal Articles

No Association between Chlamydia Psittaci and Ocular Adnexal Lymphoma in North American Samples.

Grace S. Zhang, MD, Jane N. Winter, MD, Daina Variakojis, MD, Steven Reich, Gary S. Lissner, MD, Paul Bryar, MD, Mary Ann Regner, Kathy Mangold, Karen Kaul, MD, Ph.D

Blood (2005) 106 (11): 999.

https://doi.org/10.1182/blood.V106.11.999.999

Published: 2005

Journal Articles

Chlamydia Psittaci -Eradicating Antibiotic Therapy as a Potential Therapeutic Strategy Against Marginal Zone B-Cell Lymphoma of the Ocular Adnexa.

Andres J. Ferreri, MD, Maurilio Ponzoni, MD, Massimo Guidoboni, MD, Antonia A. Lettini, MD, Laura Caggiari, MD, Carlo De Conciliis, MD, Antonio Giordano Resti, MD, Benedetta Mazzi, MD, Rosalba Stefano, MD, Mauro Boiocchi, MD, Claudio Doglioni, MD, Eugenio Villa, MD, Riccardo Dolcetti, MD

Blood (2004) 104 (11): 3274.

https://doi.org/10.1182/blood.V104.11.3274.3274

Published: 2004

NARROW

Genetic Landscape of Ocular Adnexa Extranodal Marginal Zone Lymphoma

Limited Role of Workup Including PET-CT, Esophagogastroduodenoscopy and Bone Marrow Biopsy in Staging of Ocular Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Type

R-CVP Chemoimmunotherapy for Limited-Stage Ocular Adnexal MALT Lymphoma with Adverse Factors: A Phase II Study

A Novel Prognostic Index for Ocular Adnexal Lymphoma

Chemotherapy Alone Is Effective to Treat Localized and Disseminated Ocular Adnexa Lymphomas

Ocular Adnexal Marginal Zone Lymphomas (OAMZL): Lack of Evidence for Chlamydia Psittaci (C. Psittaci) Infection in a Clinicopathologic Study from a Single Institution

Ocular Adnexal Lymphomas (OALs) At Conjunctiva Present a Remarkable Good Prognosis : Oals Study Of 83 Cases At a Single Institution

MicroRNA Profiling in Low-Grade Ocular MALT and Diffuse Large B-Cell Lymphoma: A Role for MYC and NFKB1 Mediated Dysregulation of MicroRNA Expression in Aggressive Disease

Rituximab and Chlorambucil As First Line Therapy of Low-Grade Ocular Adnexal Lymphomas: Long Term Follow-up Results

Primary and Secondary Ocular Adnexal Lymphoma: A Single Institutional Experience

Extranodal marginal zone lymphoma of the ocular adnexa

Immunoglobulin Gene Repertoire in Ocular Adnexa Lymphomas (OAL): Hints on the Nature of the Antigenic Stimulation

First Line Treatment with Rituximab and Chlorambucil in the Treatment of Ocular Adnexal Lymphomas.

High Prevalence of Helicobacter pylori ( Hp ) Infection in Ocular Adnexal Lymphoma (OAL).

Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci

Ocular Adnexal Lymphoma: A Clinicopathological Study of a Large Cohort of Patients with No Evidence for an Association with Chlamydia psittaci .

Is There an Association between Ocular Adnexal Lymphoma and Chlamydia psittaci Infection? The University of Rochester Experience.

No Association between Chlamydia Psittaci and Ocular Adnexal Lymphoma in North American Samples.

Chlamydia Psittaci -Eradicating Antibiotic Therapy as a Potential Therapeutic Strategy Against Marginal Zone B-Cell Lymphoma of the Ocular Adnexa.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only